INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

Tariq Musa reported GH

Director · Guardant Health, Inc. · Guardant Health, Inc. — Restricted Stock Units

Side
M
Value
—
Shares
249
Price
—
Executed
Sep 15, 2026
Disclosed
Sep 17, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 15 executedSep 17, 2026 disclosed

GH · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+5 / 25

No reported dollar value · 19.9% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+1 / 15

    Routine: 6 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GH

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Oct 17, 2026Oct 19, 2026
    traded Oct 17, 2026
    		+2dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$19K
    116 sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    250 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    28
    Jonathan L. JacksonDJoint
    GHGuardant Health, Inc.
    Purchase
    		BUY$15K – $50KSep 28, 2026Oct 19, 2026
    traded Sep 28, 2026
    		+21dHOUSE PTR

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Oct 17, 2026Oct 19, 2026
    traded Oct 17, 2026
    		+2dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    250 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,340 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,701 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    3,324 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    13
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,701 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    15
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Tax withholding
    		F$755K
    4,320 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    13
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    3,324 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,340 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,668 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,668 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Sep 17, 2026Sep 21, 2026
    traded Sep 17, 2026
    		+4dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Sep 17, 2026Sep 21, 2026
    traded Sep 17, 2026
    		+4dSEC FORM 4

    Evidence

    8
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$20K
    116 sh
    		Sep 16, 2026Sep 17, 2026
    traded Sep 16, 2026
    		+1dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    249 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    40
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Open-market sale
    		SELL$1.38M
    7,738 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001968281-26-000025
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 15, 2026
    Published
    Sep 17, 2026
    Ingested by INSIDER
    Nov 5, 02:16 UTC
    Last re-read
    Nov 5, 02:16 UTC

    Extracted facts

    Filer
    Tariq Musa
    Role
    Director
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Guardant Health, Inc. — Restricted Stock Units
    Ticker
    GH
    Shares
    249
    Price per share
    $0
    Execution date (reported)
    Sep 15, 2026
    Owned after transaction
    1,500 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    What this establishes

    Tariq Musa filed this Form 4 reporting a option exercise of GH on Sep 15, 2026. It became public on Sep 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Tariq Musacik:0001968281
    Issuer
    Guardant Health, Inc.cik:0001576280

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.